AnaptysBio Inc. Company Profile
NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
45.65-2.24 (-4.68%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 45.65 0.00%
AnaptysBio at a glance
AnaptysBio Inc. (NASDAQ: ANAB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2017. At a market capitalization of $1.42 billion, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001370053, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- AnaptysBio Inc.
- Ticker
- NASDAQ: ANAB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2017
- Market cap
- $1.42B
- SEC CIK
- 0001370053
Companies similar to AnaptysBio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TYRATyra Biosciences Inc. | 20.39 | +0.74% | $1.40B | vs ANAB |
| AAPGAscentage Pharma Group International American Depository Shares | 14.94 | -7.15% | $1.40B | vs ANAB |
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs ANAB |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs ANAB |
| NKTRNektar Therapeutics | 40.26 | +0.88% | $1.37B | vs ANAB |
| RAREUltragenyx Pharmaceutical Inc. | 14.89 | +2.97% | $1.47B | vs ANAB |
| KLRAKailera Therapeutics Inc. | 10.53 | -2.77% | $1.37B | vs ANAB |
| OMEROmeros Corporation | 18.75 | +1.30% | $1.36B | vs ANAB |